Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

The Journal of Experimental Medicine, 01 Feb 1968, 127(2):371-386
https://doi.org/10.1084/jem.127.2.371 PMID: 4383923 PMCID: PMC2138443

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Abstract 

Anaphylatoxin activity was derived from both human C'5 and C'3 molecules. This was achieved in the case of C'5 by interaction with trypsin or with EAC'4, (oxy)2a, 3. The smooth muscle-contracting material obtained from the treated C'5 was found to be a fragment of approximately 9,000-11,000 molecular weight. Its action was inhibited with antihistamine. The trypsinized C'5 also increased vascular permeability in guinea pig skin. When human C'3 was incubated with C'3 inactivator complex, which consists of a cobra venom protein and a beta-globulin of human serum, anaphylatoxin activity was observed. The activity was associated with a fragment cleaved from the C'3 molecule, having a molecular weight of between 6,000 and 15,000 as determined by gel filtration techniques. Similar activity was derived from C'3 by the C'3-converting enzyme in free or in cell-bound form. The C'5 anaphylatoxin failed to cross-desensitize guinea pig ileum to the contracting capacities of C'3 and guinea pig anaphylatoxin and vice versa. Anaphylatoxin prepared from C'3 by all methods mentioned above caused cross-desensitization to the other C'3 derivatives, but failed to desensitize to guinea pig anaphylatoxin.

Free full text 

Logo of jexpmedLink to Publisher's site
J Exp Med. 1968 Jan 31; 127(2): 371–386.
PMCID: PMC2138443
PMID: 4383923

THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENT

C. G. Cochrane and H. J. Müller-Eberhard
Author information Article notes Copyright and License information Disclaimer

Abstract

Anaphylatoxin activity was derived from both human C'5 and C'3 molecules. This was achieved in the case of C'5 by interaction with trypsin or with EAC'4, oxy2a, 3. The smooth muscle-contracting material obtained from the treated C'5 was found to be a fragment of approximately 9,000–11,000 molecular weight. Its action was inhibited with antihistamine. The trypsinized C'5 also increased vascular permeability in guinea pig skin. When human C'3 was incubated with C'3 inactivator complex, which consists of a cobra venom protein and a β-globulin of human serum, anaphylatoxin activity was observed. The activity was associated with a fragment cleaved from the C'3 molecule, having a molecular weight of between 6,000 and 15,000 as determined by gel filtration techniques. Similar activity was derived from C'3 by the C'3-converting enzyme in free or in cell-bound form. The C'5 anaphylatoxin failed to cross-desensitize guinea pig ileum to the contracting capacities of C'3 and guinea pig anaphylatoxin and vice versa. Anaphylatoxin prepared from C'3 by all methods mentioned above caused cross-desensitization to the other C'3 derivatives, but failed to desensitize to guinea pig anaphylatoxin.

Full Text

The Full Text of this article is available as a PDF (907K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • da Silva WD, Eisele JW, Lepow IH. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3. J Exp Med. 1967 Dec 1;126(6):1027–1048. [Europe PMC free article] [Abstract] [Google Scholar]
  • OSLER AG, RANDALL HG, HILL BM, OVARY Z. Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin. J Exp Med. 1959 Aug 1;110(2):311–339. [Europe PMC free article] [Abstract] [Google Scholar]
  • Dias Da Silva W, Lepow IH. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med. 1967 May 1;125(5):921–946. [Europe PMC free article] [Abstract] [Google Scholar]
  • Jensen J. Anaphylatoxin in its relation to the complement system. Science. 1967 Mar 3;155(3766):1122–1123. [Abstract] [Google Scholar]
  • Polley MJ, Müller-Eberhard HJ. Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967 Dec 1;126(6):1013–1025. [Europe PMC free article] [Abstract] [Google Scholar]
  • NILSSON UR, MUELLER-EBERHARD HJ. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. [Europe PMC free article] [Abstract] [Google Scholar]
  • MUELLER-EBERHARD HJ, BIRO CE. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. [Europe PMC free article] [Abstract] [Google Scholar]
  • Nilsson UR, Müller-Eberhard HJ. Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis. Immunology. 1967 Jul;13(1):101–117. [Abstract] [Google Scholar]
  • McConahey PJ, Dixon FJ. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. [Abstract] [Google Scholar]
  • Müllerèberhard HJ, Dalmasso AP, Calcott MA. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis. J Exp Med. 1966 Jan 1;123(1):33–54. [Europe PMC free article] [Abstract] [Google Scholar]
  • Müller-Eberhard HJ, Polley MJ, Calcott MA. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med. 1967 Feb 1;125(2):359–380. [Europe PMC free article] [Abstract] [Google Scholar]
  • NORTON S. Quantitative determination of mast cell fragmentation by compound 48/80. Br J Pharmacol Chemother. 1954 Dec;9(4):494–497. [Europe PMC free article] [Abstract] [Google Scholar]
  • Cooper NR, Becker EL. Complement associated peptidase activity of guinea pig serum. I. Role of complement components. J Immunol. 1967 Jan;98(1):119–131. [Abstract] [Google Scholar]
  • STEGEMANN H, VOGT W, FRIEDBERG KD. UBER DIE NATUR DES ANAPHYLATOXINS. Hoppe Seylers Z Physiol Chem. 1964;337:269–276. [Abstract] [Google Scholar]
  • Stegemann H, Bernhard G, O'Neil JA. Endgruppen von Anaphylatoxin. Einfache Sequenzanalyse von Carboxyl-endständigen Aminosäuren. Hoppe Seylers Z Physiol Chem. 1964;339(1):9–13. [Abstract] [Google Scholar]
  • STEGEMANN H, HILLEBRECHT R, RIEN W. ZUR CHEMIE DES ANAPHYLATOXINS. Hoppe Seylers Z Physiol Chem. 1965;340:11–17. [Abstract] [Google Scholar]
Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

Full text links 

Read article at publisher's site: https://doi.org/10.1084/jem.127.2.371

Read article for free, from open access legal sources, via Unpaywall: https://rupress.org/jem/article-pdf/127/2/371/1082771/371.pdfUnpaywall

Citations & impact 

Impact metrics

250
Citations
Jump to Citations

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1084/jem.127.2.371

Supporting
Mentioning
Contrasting
1
144
3

Article citations

Go to all (250) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.